연구성과로 돌아가기
2023 연구성과별 연구자 정보 (335 / 2675)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015) | Jo, Jae-Cheol | Jo, JC | 6 | Ulsan Univ Hosp, Ulsan, South Korea | CAE-9453-2022 | Jo, Jae-Cheol | ||||
| Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015) | Yoon, Sung-Soo | Yoon, SS | 7 | Seoul Natl Univ, Coll Med, Seoul, South Korea | ||||||
| Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015) | Lim, Sung-Nam | Lim, SN | 8 | Inje Univ, Coll Med, Haeundae Paik Hosp, Busan, South Korea | ||||||
| Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015) | Do, Young Rok | Do, YR | 9 | Keimyung Univ, Dept Hematooncol, Dongsan Med Ctr, Daegu, South Korea | ||||||
| Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015) | Kim, Kihyun | Kim, K | 10 | Sungkyunkwan Univ, Samsung Med Ctr, Seoul, South Korea | D-5175-2013 | Kim, Kihyun | ||||
| Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015) | Lee, Jae Hoon | Lee, JH | 11 | Gachon Univ, Gil Med Ctr, Seongnam, South Korea | ||||||
| Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015) | Yoo, Kwai Han | Yoo, KH | 12 | Gachon Univ, Gil Med Ctr, Seongnam, South Korea | ||||||
| Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015) | Bae, Sung Hwa | Bae, SH | 13 | Daegu Catholic Univ Hosp, Daegu, South Korea | ||||||
| Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015) | Yi, Jun Ho | Yi, JH | 14 | Chung Ang Univ Hosp, Seoul, South Korea | GXZ-8144-2022 | Yi, Jun Ho | ||||
| Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015) | Jung, Jongheon | Jung, J | 15 | Natl Canc Ctr, Goyang, South Korea | ||||||
| Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015) | Eom, Hyeon-Seok | Eom, HS | 16 | Natl Canc Ctr Korea, Dept Internal Med, Goyang, South Korea | ||||||
| Butyrate producers, "The Sentinel of Gut": Their intestinal significance with and beyond butyrate, and prospective use as microbial therapeutics | Singh, Vineet | Singh, V | 1 | Kyungpook Natl Univ, Dept Appl Biosci, Daegu, South Korea | ABC-7000-2021 | Singh, Vineet | 0000-0003-2458-3282 | Singh, Vineet | tatsu@jejunu.ac.kr;jhshin@knu.ac.kr; | |
| Butyrate producers, "The Sentinel of Gut": Their intestinal significance with and beyond butyrate, and prospective use as microbial therapeutics | Lee, GyuDae | Lee, GD | 2 | Kyungpook Natl Univ, Dept Appl Biosci, Daegu, South Korea | tatsu@jejunu.ac.kr;jhshin@knu.ac.kr; | |||||
| Butyrate producers, "The Sentinel of Gut": Their intestinal significance with and beyond butyrate, and prospective use as microbial therapeutics | Son, HyunWoo | Son, HW | 3 | Kyungpook Natl Univ, Dept Appl Biosci, Daegu, South Korea | tatsu@jejunu.ac.kr;jhshin@knu.ac.kr; | |||||
| Butyrate producers, "The Sentinel of Gut": Their intestinal significance with and beyond butyrate, and prospective use as microbial therapeutics | Koh, Hong | Koh, H | 4 | Yonsei Univ Coll Med, Severance Hosp, Severance Fecal Microbiota Transplantat Ctr, Dept Pediat, Seoul, South Korea | tatsu@jejunu.ac.kr;jhshin@knu.ac.kr; |
페이지 이동: